High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$5.1M
$5,052,611
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $123,267 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $41,326 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $214,207 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $38,721 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $368,761 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $178,924 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $126,025 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Other
|
2025-09-17 | $164,778 | M | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Jacobs Bruce N.
• CFO
10b5-1 SellΔOwn -25.8%
2025-09-17
$3,961,380Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -25.8%
|
2025-09-17 | $3,961,380Large | S | Form 4 |